Research ExplorerPublicationsMeta-analysis of the prognostic value of circulating tumor c...

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.

Standard

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. / Zhang, Liling; Riethdorf, Sabine; Wu, Gang; Wang, Tao; Yang, Kunyu; Peng, Gang; Liu, Junli; Pantel, Klaus.

In: CLIN CANCER RES, Vol. 18, No. 20, 20, 2012, p. 5701-5710.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Zhang, L, Riethdorf, S, Wu, G, Wang, T, Yang, K, Peng, G, Liu, J & Pantel, K 2012, 'Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.', CLIN CANCER RES, vol. 18, no. 20, 20, pp. 5701-5710. <http://www.ncbi.nlm.nih.gov/pubmed/22908097?dopt=Citation>

APA

Zhang, L., Riethdorf, S., Wu, G., Wang, T., Yang, K., Peng, G., Liu, J., & Pantel, K. (2012). Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. CLIN CANCER RES, 18(20), 5701-5710. [20]. http://www.ncbi.nlm.nih.gov/pubmed/22908097?dopt=Citation

Vancouver

Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. CLIN CANCER RES. 2012;18(20):5701-5710. 20.

Bibtex

@article{f5f8bb51bb9b4a4cb5ea4aa89730f20e,
title = "Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.",
abstract = "The prognostic value of circulating tumor cells (CTC) detected in breast cancer patients is currently under debate. Different time points of blood collections and various CTC assays have been used in the past decades. Here, we conducted the first comprehensive meta-analysis of published literature on the prognostic relevance of CTC, including patients with early and advanced disease.",
keywords = "Humans, Female, Disease-Free Survival, Neoplasm Staging, Neoplasm Metastasis, *Prognosis, Neoplastic Cells, Circulating/*metabolism, *Breast Neoplasms/blood/metabolism, Humans, Female, Disease-Free Survival, Neoplasm Staging, Neoplasm Metastasis, *Prognosis, Neoplastic Cells, Circulating/*metabolism, *Breast Neoplasms/blood/metabolism",
author = "Liling Zhang and Sabine Riethdorf and Gang Wu and Tao Wang and Kunyu Yang and Gang Peng and Junli Liu and Klaus Pantel",
year = "2012",
language = "English",
volume = "18",
pages = "5701--5710",
journal = "CLIN CANCER RES",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

RIS

TY - JOUR

T1 - Meta-analysis of the prognostic value of circulating tumor cells in breast cancer.

AU - Zhang, Liling

AU - Riethdorf, Sabine

AU - Wu, Gang

AU - Wang, Tao

AU - Yang, Kunyu

AU - Peng, Gang

AU - Liu, Junli

AU - Pantel, Klaus

PY - 2012

Y1 - 2012

N2 - The prognostic value of circulating tumor cells (CTC) detected in breast cancer patients is currently under debate. Different time points of blood collections and various CTC assays have been used in the past decades. Here, we conducted the first comprehensive meta-analysis of published literature on the prognostic relevance of CTC, including patients with early and advanced disease.

AB - The prognostic value of circulating tumor cells (CTC) detected in breast cancer patients is currently under debate. Different time points of blood collections and various CTC assays have been used in the past decades. Here, we conducted the first comprehensive meta-analysis of published literature on the prognostic relevance of CTC, including patients with early and advanced disease.

KW - Humans

KW - Female

KW - Disease-Free Survival

KW - Neoplasm Staging

KW - Neoplasm Metastasis

KW - Prognosis

KW - Neoplastic Cells, Circulating/metabolism

KW - Breast Neoplasms/blood/metabolism

KW - Humans

KW - Female

KW - Disease-Free Survival

KW - Neoplasm Staging

KW - Neoplasm Metastasis

KW - Prognosis

KW - Neoplastic Cells, Circulating/metabolism

KW - Breast Neoplasms/blood/metabolism

M3 - SCORING: Journal article

VL - 18

SP - 5701

EP - 5710

JO - CLIN CANCER RES

JF - CLIN CANCER RES

SN - 1078-0432

IS - 20

M1 - 20

ER -